# Shape Pharmaceuticals, Inc. — Form D

Shape Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-10-12. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2010-10-12
- Form: D
- Accession: 0001140361-10-040810
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $2.0M
- Minimum investment: $2.0M
- Investors: 1
- Date of first sale: 2008-11-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-148861

## Issuer

- Name: Shape Pharmaceuticals, Inc.
- CIK: 0001500398
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA, 02142
- Phone: 617 997 9881

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Douglas E Onsi | Director | Cambridge, MA |
| Douglas E Onsi | Executive Officer | Cambridge, MA |
| Augustine E Lawlor | Director | Cambridge, MA |
| James E Bradner | Director | Cambridge, MA |
| Paul E Marks | Director | Cambridge, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2010-10-12](https://search.stillhousedata.com/formd/0001140361-10-040811) | D | $4.5M | $1.0M |

## More

- [CIK 1500398 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1500398&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001140361-10-040810.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.